| Literature DB >> 32694929 |
Valter Paulo Neves Miranda1, Paulo Roberto Dos Santos Amorim2, Ronaldo Rocha Bastos3, Karina Lúcia Ribeiro Canabrava4, Márcio Vidigal Miranda Júnior5, Fernanda Rocha Faria1, Sylvia do Carmo Castro Franceschini6, Maria do Carmo Gouveia Peluzio6, Silvia Eloiza Priore6.
Abstract
BACKGROUND: Female adolescents are considered a risk group for cardiometabolic disease due to their lifestyle (LS).Entities:
Mesh:
Year: 2020 PMID: 32694929 PMCID: PMC7368183 DOI: 10.1155/2020/9170640
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Latent Class Analysis model of female adolescents' lifestyle (LS). ∗Prevalence (γ) of latent class. ρ: item-response probability. Class 1: Active & Sedentary LS (γ = 6.19%); Class 2: Inactive & Non-Sedentary LS (γ = 16.31%); Class 3: Inactive & Sedentary LS (γ = 77.5%). MVPA: Moderate to Vigorous Physical Activity.
Absolute and relative frequencies of female adolescents' lifestyle cardiometabolic diseases risk factors.
| Variables | Absolute frequency ( | Relative frequency (%) |
|---|---|---|
| BMI & BF%∗ (DEXA) ( | ||
| LW-EUT & adequate BF% (G1) | 179 | 45.31 |
| EUT & high BF% (G2) | 126 | 31.90 |
| OW-OB & high BF% (G3) | 90 | 22.78 |
| Neck circumference (cm) ( | ||
| Adequate neck circumference | 388 | 95.80 |
| High neck circumference | 17 | 4.20 |
| Blood pressure (mmHg) ( | ||
| Normotensive | 332 | 83 |
| High blood pressure | 68 | 17 |
| Total cholesterol (mg/dL) ( | ||
| Adequate total cholesterol | 218 | 54.09 |
| High total cholesterol | 185 | 45.91 |
| HDL (mg/dL) ( | ||
| Adequate HDL | 274 | 67.99 |
| Low HDL | 129 | 32.01 |
| LDL (mg/dL) ( | ||
| Adequate LDL | 317 | 78.66 |
| High LDL | 86 | 21.34 |
| Triglycerides (mg/dL) ( | ||
| Adequate triglycerides | 338 | 83.87 |
| High triglycerides | 65 | 16.13 |
| Glucose (mg/dL) ( | ||
| Adequate glucose | 395 | 98.70 |
| High glucose | 5 | 1.30 |
| Insulin (mUI/mL) ( | ||
| Adequate insulin | 379 | 95.20 |
| High insulin | 19 | 4.80 |
| HOMA-IR ( | ||
| Adequate HOMA-IR | 367 | 92.20 |
| High HOMA-IR | 31 | 7.80 |
| Uric acid (mg/dL) ( | ||
| Adequate UA | 392 | 97.51 |
| High UA | 10 | 2.49 |
| hs-CRP (mg/dL) ( | ||
| Adequate hs-CRP | 350 | 87.28 |
| Inflammation | 51 | 12.72 |
∗Body composition classification; n: absolute frequency; BMI: body mass index; DEXA: dual-energy X-ray absorptiometry; LW: low weight; EUT: Eutrophy; OW: overweight; OB: obesity; BF%: body fat percentage; LDL: low-density lipoprotein; HDL: high-density lipoprotein; HOMA-IR: homeostasis model assessment–insulin resistance. hs-CRP: high sensitivity C-reactive protein.
Figure 2Significant differences on cardiometabolic disease risk factors and inflammatory markers among the latent classes that represent the adolescents' lifestyle. ∗Significant p values (p < 0.05) of Kruskal-Wallis test; †significant p values of Mann-Whitney test after Bonferroni correction (≤0.0166) between groups 1 and 3; ‡nonsignificant p values of Mann-Whitney after Bonferroni correction (>0.0166) between classes 1 and 2. LCA: Latent Class Analysis.
Quantitative values of the cardiometabolic disease risk factors among the groups of body composition.
| Quantitative values of CD factors | Group 1 LW-EUT & adequate BF% ( | Group 2 EUT & high BF% ( | Group 3 OW-OB & high BF% ( |
|
|---|---|---|---|---|
| Median (P25-P75) | Median (P25-P75) | Median (P25-P75) | ||
| WC (cm) | 66.0 (63.0-68.2)¥† | 71.3 (68.5-74.0)¥‡ | 82.6 (78.7-87.8)†‡ | <0.001∗ |
| WHtR | 0.40 (0.39-0.42)¥† | 0.43 (0.42-0.46)¥‡ | 0.51 (0.48-0.53)†‡ | <0.001∗ |
| NC | 29.6 (29.0-30.7)¥† | 30.5 (29.5-31.2)¥‡ | 32.6 (31.2-33.5)†‡ | <0.001∗ |
| SBP (mmHg) | 103.5 (99.0-110.0)† | 105.5 (100.0-111.3)‡ | 111.2 (105.0 – 120.3)†‡ | <0.001∗ |
| DBP (mmHg) | 69.0 (63.5-73.5)† | 70.0 (65.5-74.5)‡ | 73.7 (67.6-79.9)†‡ | <0.001∗ |
| Total cholesterol (mg/dL) | 145.0 (132.0-161.5) | 150.0 (132.2-164.0) | 150.5 (134.5-173.2) | 0.134 |
| HDL (mg/dL) | 52.0 (46.0-58.0)† | 49.0 (42.0-58.0) | 46.0 (39.7-54.0)† | <0.001∗ |
| LDL (mg/dL) | 78.8 (64.9-94.6)† | 84.5 (70.2-96.3) | 87.5 (71.9-109.3)† | 0.018∗ |
| VLDL (mg/dL) | 12.6 (9.4-16.0)† | 13.5 (10.6-17.6) | 14.1 (10.8-18.8)† | 0.01∗ |
| Triglycerides (mg/dL) | 63.0 (47.0-80.0)† | 67.5 (53.2-88.0) | 70.5 (54.0-94.2)† | 0.01∗ |
| Glucose (mg/dL) | 85.0 (80.0-89.0)† | 85.0 (80.0-88.0) | 87.0 (82.0-91.0)† | 0.032∗ |
| Insulin (mUI/mL) | 5.8 (4.6-7.7)† | 6.6 (4.8-8.6)‡ | 9.1 (6.3-12.9)†‡ | <0.01∗ |
| HOMA-IR | 1.3 (1.0-1.7)† | 1.5 (1.0-1.9)‡ | 2.0 (1.3-3.1)†‡ | <0.001∗ |
| Uric acid (mg/dL) | 3.4 (2.9-3.9)† | 3.6 (3.0-4.2)‡ | 3.9 (3.5-4.9)†‡ | <0.001∗ |
| hs-CRP (mg/dL) | 0.04 (0.02-0.10)† | 0.07 (0.03-0.17) | 0.10 (0.04-0.26)† | <0.001∗ |
| IL-6 (pg/mL) | 1.9 (1.2-2.8) | 1.8 (1.3-2.8) | 2.2 (1.3-3.0) | 0.434 |
| TNF- | 1.8 (1.2-2.7) | 2.2 (1.2-2.8) | 2.1 (1.4-2.8) | 0.148 |
| Leptin (pg/mL) | 3207.0 (2144.0-4930.0)† | 5944.0 (3800.0-7794.5)‡ | 9521.0 (6505.7-14175.2)†‡ | <0.001∗ |
| IL-10 (pg/mL) | 1.36 (0.9-2.0) | 1.4 (1.0-2.3) | 1.4 (1.0-2.1) | 0.295 |
∗Significant p values (p < 0.005) of Kruskal-Wallis test; ¥significant p values of Mann-Whitney test after Bonferroni correction (≤0.0166) between groups 1 and 2; †significant p values of Mann-Whitney test after Bonferroni correction (≤0.0166) between groups 1 and 3; ‡significant p values of Mann-Whitney test after Bonferroni correction (>0.0166) between groups 2 and 3. LW: low weight; EUT: Eutrophy; OW: overweight; OB: obesity; BF%: body fat percentage; SBP: systolic blood pressure; WC: waist circumference; WHtR: waist-to-height ratio; NC: neck circumference; DBP: diastolic blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very-low-density lipoprotein; HOMA-IR: homeostasis model assessment–insulin resistance; hs-CRP: high sensitivity C-reactive Protein; IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; IL-10: interleukin-10.
Multiple linear regression model referent to the association among inflammatory markers, lifestyle (LCA model), and cardiometabolic disease risk factors.
|
| |||||||
|---|---|---|---|---|---|---|---|
| Independent variables |
| CI 95% ln (exp) | Standardized |
|
| Adjusted | F test |
| LCA model | 1 | — | — | 0.044 | 0.038 |
| |
| Inactive & sedentary LS | 0.221 (1.24) | 0.069 (1.07)-0.374 (1.45) | 0.161 (1.17) | 0.005 | |||
| hs-CRP | 0.31 (1.36) | 0.127 (1.13)-0.494 (1.63) | 0.187 (1.20) | 0.001 | |||
|
| |||||||
|
| |||||||
| Independent variable |
| CI 95% ln (exp) | Standardized |
|
|
| F test |
| HOMA-IR | 0.319 (1.37) | 0.239 (1.26)-0.399 (1.49) | — | 0.026 | 0.013 | — | — |
|
| |||||||
|
| |||||||
| Independent variable |
| CI 95% ln (exp) | Standardized |
|
|
| F test |
| BF% | 0.064 (1.06) | 0.057 (1.05)-0.072 (1.07) | 0.431 (1.53) | <0.001 | 0.34 | 0.335 | <0.001 |
| HOMA-IR | 0.101 (1.10) | 0.036 (1.03)-0.166 (1.18) | 0.186 (1.20) | <0.001 | |||
‡The method for selecting variables was backward. #Class 1 and class 2 collapsed; †Cardiometabolic markers that showed normal distribution after logarithmic transformation. ∗Standardized β-coefficient was not used because with IL-6 only one variable showed association. ln: β-coefficient values presented for natural logarithm of independent variables; exp:: exp(β)-; TNF-α: tumor necrosis factor-α; IL-6: Interleukin-6; BF%: body fat percentage; hs-CRP: high sensitivity C-reactive protein; HOMA-IR: homeostasis model assessment–insulin resistance.